Schedule 13G ownership disclosure

BIOCRYST PHARMACEUTICALS INC

Security class unavailable · CUSIP: 09058V103

Event date: 2018-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,622,256
Percent of class
6.9500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000930413-19-000073
Form type
SC 13G
Filer
BIOCRYST PHARMACEUTICALS INC
CIK
CIK 882796
Filed
Jan 11, 2019
Reporting period
Dec 31, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub